Clinical Decision Support System: An Effective Tool to Detect and Manage Drug-Laboratory Interactions

Authors

  • Freidooni, Mahsa M.Sc. in Medical Informatics, Health Information Technology Dept., Urmia University of Medical Sciences, Urmia, Iran
  • Niazkhani , Zahra Ph.D. in Medical Informatics, Associate Professor, Nephrology and Kidney Transplant Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran
  • Pirnejad , Habibollah Ph.D. in Medical Informatics, Associate Professor, Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran
Abstract:

Lack of proper linkage between a patient’s medications and the results of laboratory tests can lead to common medication errors called drug-laboratory interactions (DLIs). DLIs are among the major types of preventable medication errors in the treatment process. Application of a clinical decision support system (CDSS) for physicians and other health care providers to decrease DLIs can effectively improve the treatment process and care quality helping to prevent potential adverse drug events. Design and implementation of these systems requires measurements to tackle a number of challenges. The present article briefly reviews these challenges and provides solutions to increase their effectiveness. With informed design and implementation of DLI-CDSSs, it is hoped that these interactions will be decreased and the quality of prescriptions will be improved with regard to patients’ laboratory test results.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them

Drug-drug interactions (DDIs) are a common source of preventable medical errors in inpatient and outpatient settings of both developed and developing countries. When two or more drugs are simultaneously prescribed, interactions between their effects may result in preventable adverse events such as damages to vital organs, frequent hospitalizations, prolonged length of hospital stay, and increas...

full text

Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them

Drug-drug interactions (DDIs) are a common source of preventable medical errors in inpatient and outpatient settings of both developed and developing countries. When two or more drugs are simultaneously prescribed, interactions between their effects may result in preventable adverse events such as damages to vital organs, frequent hospitalizations, prolonged length of hospital stay, and increas...

full text

Designing Decision Support System to Detect Drug Interactions Type 2 Diabetes

BACKGROUND AND AIM Type II Diabetes is the most common diseases of metabolic disorders and the treatment of oral anti-diabetic drug use takes place But The problem of using multi-drug and interactions at the same time is an issue that has always been a major challenge And diagnosis of drug interactions, particularly in Diabetic patients due to the problem with the disease is very important. The...

full text

Developing a New Decision Support System to Manage Human Reliability based on HEART Method

Human performance and reliability monitoring have become the main issue for many industries since human error ratios cannot be mitigated to the zero level and many accidents, malfunctions, and quality defects are happening due to the human in production systems. Since the human resources implement a different range of tasks, the calculation of human error probability (HEP) is complicated, and s...

full text

Recommendations for selecting drug-drug interactions for clinical decision support.

PURPOSE Recommendations for including drug-drug interactions (DDIs) in clinical decision support (CDS) are presented. SUMMARY A conference series was conducted to improve CDS for DDIs. A work group consisting of 20 experts in pharmacology, drug information, and CDS from academia, government agencies, health information vendors, and healthcare organizations was convened to address (1) the proc...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 4

pages  466- 473

publication date 2021-03

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023